Adam Sampson-Johannes

University of North Carolina at Chapel Hill — United States

Immunology and Microbiology · Life Sciences

15h-index4.8kcitations21works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Response and Inflammation(7), Virus-based gene therapy research(7), Cancer Research and Treatments(5), Immune cells in cancer(4), CAR-T cell therapy research(4)

Publications21 total

Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity
UNC Libraries·2019Open Access
Photochemical Inactivation of Chikungunya Virus in Human Apheresis Platelet Components by Amotosalen and UVA Light
American Journal of Tropical Medicine and Hygiene·2013· 25 citedOpen Access
Inactivation of Pathogens in Red Blood Cells by a Modified Treatment Process Utilizing S-303 and Glutathione.
Blood·2006· 2 cited
Inactivation of Emergent Blood-borne Pathogens in Plasma and Platelets
2006
Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates
Transfusion Medicine·2005· 44 citedOpen Access
Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity
Nature Medicine·2005· 133 citedOpen Access
Developing Novel Oncolytic Adenoviruses through Bioselection
Journal of Virology·2003· 54 citedOpen Access
Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status
Gene Therapy·2000· 66 citedOpen Access
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
Nature Medicine·2000· 584 cited
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
Nature Medicine·1997· 944 cited
ONYX-015: An adenovirus attenuated in the E1B-55KD gene selectively replicates in, and causes lysis of, P53- tumor cells
European Journal of Cancer·1997
The Candidates Speak
Science·1996· 2 cited
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
Science·1996· 1.8k cited
Colonization of human lung grafts in SCID-hu mice by human colon carcinoma cells
International Journal of Cancer·1996· 28 cited
IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor
The Journal of Immunology·1992· 227 citedOpen Access
Negative Regulation of Cytokines Inhibition of the Production of Interleukin‐1 and Tumor Necrosis Factor
Annals of the New York Academy of Sciences·1991· 3 cited
Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity
Cell·1991· 728 cited
Macrophage growth and stimulating factor, M-CSF.
PubMed·1990· 20 cited
Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
The Journal of Immunology·1988· 75 cited
CSF-1 and c-fms gene expression in human carcinoma cell lines
Biochemical and Biophysical Research Communications·1988· 42 cited
page 1 of 2Next →

Frequent Co-authors

David H. Kirn(6), Carla Heise(6), Angelica Williams(4), Frank McCormick(4), Mike Muna(3), Ali Fattaey(3), P Ralph(3), Ilona Nakoinz(3), Lynette Sawyer(3), James R. Bischoff(2), Sharon T. Horn(2), Lelia Ng(2), Julie A. Nye(2), Stephen Haskill(2), S. Mark Tompkins(2), Andrew D. Yurochko(2), Krishna Mondal(2), Peter Ralph(2), Terry Hermiston(2), Thomas W. Dubensky(2)